GenomeKey
GenomeKey is an artificial intelligence company in Bristol, United Kingdom, founded in 2019. It has raised $11.7M across 2 rounds, most recently an $11.4M Grant in April 2021.
- Headquarters
- Bristol
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- genomekey.com
- Total Funding
- $11.7M
- Last Round
- $11.4M GrantApr 2021
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
UK biotechnology company using AI machine learning to build an in vitro diagnostic device that identifies bacterial species and antibiotic resistance directly from patient blood.
Summary
It lists 11–50 employees. It has raised $11.7M in total across 2 rounds, most recently a $11.4M Grant round in Apr 2021. Investors include CARB-X and Bristol Private Equity Club.
Funding History
Apr 2021
Sign up to see all 2 events
Funding: Angel through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/genomekey"><img src="https://indexed.vc/api/badge/company/genomekey" alt="GenomeKey on Indexed.vc" width="260" height="76" /></a>